Picture of Healthbeacon logo

HBCN Healthbeacon News Story

0.000.00%
ie flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

REG - HealthBeacon PLC HealthBeacon - HBCN - Update on Examinership Process

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240129:nRSc1735Ba&default-theme=true

RNS Number : 1735B  HealthBeacon PLC  29 January 2024

 

 

Update on Examinership Process

 

 

Dublin, 29 January 2024.  The board of HealthBeacon plc ("HealthBeacon" or
the "Company) announces an update on the Examinership process the Company is
currently going through.

 

The Examiner held meetings of all members and creditors of the Company on
Wednesday 24 January 2024 for the purpose of considering and voting on a
Scheme of Arrangement to allow the Company survive as a going concern. All 5
classes of creditors voted to approve the scheme. The meeting of the members
voted to reject the proposals, although a majority in number but not value
voted for the scheme.

 

The Examiner has now presented his report to the High Court under section 534
of the Companies Act 2014 and it is anticipated that the hearing seeking
sanction from the High Court of the Scheme of Arrangement will be heard by the
end of next week following which the Company will make a further announcement.

 

 

-Ends-

 

 Enquiries:                                       Investor.Relations@HealthBeacon.com
                                                  (mailto:Investor.Relations@HealthBeacon.com)
 HealthBeacon:

 Rebecca Shanahan

 Lar Malone

 Goodbody (Euronext Listing Sponsor and Broker):  +353 (1) 667 0420

 Finbarr Griffin

 Drury (Public Relations):
 Cathal Barry                                     +353 (0) 87 227 9281
 Gavin McLoughlin                                 +353 (0) 86 035 3749

 

About HealthBeacon

Headquartered in Dublin, HealthBeacon is an Irish digital therapeutics company
that develops smart tools for managing medications for patients in the home.
The HealthBeacon Injection Care Management System tracks adherence and
persistence with medication schedules through the provision of medication
management reminders, safe and sustainable sharps disposal devices,
educational tools, and artificial intelligence (AI) driven data analytics.
Peer reviewed evidence supports a 19% improvement in therapy persistence by
patients and up to 26% improvement in adherence to therapy, which improves
clinical outcomes and significantly improves efficiency in health systems. The
Company has expanded its offering to growth management with the launch of its
integrated Smart Scale and oral adherence with the launch of HB Wave which
integrates with its existing technology. The Company operates across Europe,
North America and the United Kingdom and employs more than 70 people and has
obtained more than 30 design and utility patents. The Company's mission is to
become the world's leading digital therapeutics platform for patients managing
medications in the home.

End

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ISEDXGDBDBDDGSI

Recent news on Healthbeacon

See all news